Literature DB >> 21338179

Long-term trends in cancer mortality in Korea (1983-2007): a joinpoint regression analysis.

Kyu-Won Jung1, Hai-Rim Shin, Hyun-Joo Kong, Sohee Park, Young-Joo Won, Kui Son Choi, Eun-Cheol Park.   

Abstract

Cancer has been the most common cause of death in Korea since 1983 and is a major public concern. The aim of this study was to analyze the secular trend of cancer mortality in Korea from 1983 to 2007. Mortality and population data from 1983 to 2007 were obtained from the Korea Statistical Office. The annual cancer death rates for 18 age groups were estimated, and joinpoint regression was applied to detect significant changes in cancer mortality. The age-standardized mortality rate for all sites combined increased until the mid-1990s and has been decreasing thereafter, this also being the case for cancers of the esophagus, liver, lung and bladder, as well as leukemia. With stomach and uterine cancers a constant reduction was evident throughout the period. The declines in stomach, liver, and uterine cancer mortality have made major contributions to the recent overall favorable trend. Mortality for cancers of the colon and rectum and the prostate increased in the early 2000s and then leveled off, whereas female breast cancer mortality has displayed a constant increasing trend. In conclusion, overall cancer mortality is decreasing in men and women in Korea, and this trend will probably continue and improve further in line with advances in management as well as the expected impact of the national screening program for major five cancers over the next decades.

Entities:  

Mesh:

Year:  2010        PMID: 21338179

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  12 in total

Review 1.  Global trends of lung cancer mortality and smoking prevalence.

Authors:  Farhad Islami; Lindsey A Torre; Ahmedin Jemal
Journal:  Transl Lung Cancer Res       Date:  2015-08

2.  Impact of perioperative hemoglobin levels on postoperative outcomes in gastric cancer surgery.

Authors:  Do-Hyun Jung; Hyuk-Joon Lee; Dong-Seok Han; Yun-Suhk Suh; Seong-Ho Kong; Kuhn-Uk Lee; Han-Kwang Yang
Journal:  Gastric Cancer       Date:  2012-09-25       Impact factor: 7.370

Review 3.  Prostate cancer in Asian men.

Authors:  Kazuto Ito
Journal:  Nat Rev Urol       Date:  2014-03-04       Impact factor: 14.432

4.  Comparison of cancer incidence and mortality in three GDP per capita levels in China, 2013.

Authors:  Zhixun Yang; Rongshou Zheng; Siwei Zhang; Hongmei Zeng; Changfa Xia; He Li; Li Wang; Yanhong Wang; Wanqing Chen
Journal:  Chin J Cancer Res       Date:  2017-10       Impact factor: 5.087

5.  Malaria in the Americas: trends from 1959 to 2011.

Authors:  Keith H Carter; Prabhjot Singh; Oscar J Mujica; Rainier P Escalada; Maria Paz Ade; Luis Gerardo Castellanos; Marcos A Espinal
Journal:  Am J Trop Med Hyg       Date:  2014-12-29       Impact factor: 2.345

6.  Long-term trends in incidence and mortality of intrahepatic and extrahepatic bile duct cancer in Japan.

Authors:  Mai Utada; Yuko Ohno; Tomoko Tamaki; Tomotaka Sobue; Ginji Endo
Journal:  J Epidemiol       Date:  2014-03-07       Impact factor: 3.211

7.  Trends in the leading causes of death in Korea, 1983-2012.

Authors:  Daroh Lim; Mina Ha; Inmyung Song
Journal:  J Korean Med Sci       Date:  2014-11-21       Impact factor: 2.153

8.  Biomarkers in prostate cancer epidemiology.

Authors:  Mukesh Verma; Payal Patel; Mudit Verma
Journal:  Cancers (Basel)       Date:  2011-09-30       Impact factor: 6.639

Review 9.  Epidemiology of prostate cancer in the Asia-Pacific region.

Authors:  Peter D Baade; Danny R Youlden; Susanna M Cramb; Jeff Dunn; Robert A Gardiner
Journal:  Prostate Int       Date:  2013-06-30

10.  Validity of fecal occult blood test in the national cancer screening program, Korea.

Authors:  Aesun Shin; Kui Son Choi; Jae Kwan Jun; Dai Keun Noh; Mina Suh; Kyu-Won Jung; Byung Chang Kim; Jae Hwan Oh; Eun-Cheol Park
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.